Stress-Induced Depression and Alzheimer's Disease: Focus on Astrocytes

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 May 14

PMID 35563389

Authors

Oleg V Dolotov

Ludmila S Inozemtseva

Nikolay F Myasoedov

Igor A Grivennikov

Affiliations

Soon will be listed here.

Abstract

Neurodegenerative diseases and depression are multifactorial disorders with a complex and poorly understood physiopathology. Astrocytes play a key role in the functioning of neurons in norm and pathology. Stress is an important factor for the development of brain disorders. Here, we review data on the effects of stress on astrocyte function and evidence of the involvement of astrocyte dysfunction in depression and Alzheimer's disease (AD). Stressful life events are an important risk factor for depression; meanwhile, depression is an important risk factor for AD. Clinical data indicate atrophic changes in the same areas of the brain, the hippocampus and prefrontal cortex (PFC), in both pathologies. These brain regions play a key role in regulating the stress response and are most vulnerable to the action of glucocorticoids. PFC astrocytes are critically involved in the development of depression. Stress alters astrocyte function and can result in pyroptotic death of not only neurons, but also astrocytes. BDNF-TrkB system not only plays a key role in depression and in normalizing the stress response, but also appears to be an important factor in the functioning of astrocytes. Astrocytes, being a target for stress and glucocorticoids, are a promising target for the treatment of stress-dependent depression and AD.

Citing Articles

Neuroimaging Findings of Psychosis in Alzheimer's Disease: A Systematic Review.

Nabizadeh F, Sheykhlou S, Mahmoodi S, Khalili E, Zafari R, Hosseini H Brain Behav. 2024; 15(1):e70205.

PMID: 39740792 PMC: 11688121. DOI: 10.1002/brb3.70205.

The neural basis of neuropsychiatric symptoms in Alzheimer's disease.

Zhang N, Zhang S, Zhang L, Tao H, Zhang G Front Aging Neurosci. 2024; 16:1487875.

PMID: 39703925 PMC: 11655510. DOI: 10.3389/fnagi.2024.1487875.

The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer's Disease.

Jaszberenyi M, Thurzo B, Jayakumar A, Schally A Int J Mol Sci. 2024; 25(23).

PMID: 39684795 PMC: 11641508. DOI: 10.3390/ijms252313086.

Neuroinflammation and major depressive disorder: astrocytes at the crossroads.

Puentes-Orozco M, Albarracin S, Velasquez M Front Cell Neurosci. 2024; 18:1504555.

PMID: 39650796 PMC: 11620873. DOI: 10.3389/fncel.2024.1504555.

Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models).

Toledano A, Rodriguez-Casado A, Alvarez M, Toledano-Diaz A Brain Sci. 2024; 14(11).

PMID: 39595866 PMC: 11591712. DOI: 10.3390/brainsci14111101.

References

Quesseveur G, Portal B, Basile J, Ezan P, Mathou A, Halley H . Attenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice. Front Cell Neurosci. 2016; 9:490. PMC: 4686612. DOI: 10.3389/fncel.2015.00490. View

Rajkowska G, Stockmeier C . Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets. 2013; 14(11):1225-36. PMC: 3799810. DOI: 10.2174/13894501113149990156. View

Chi S, Yu J, Tan M, Tan L . Depression in Alzheimer's disease: epidemiology, mechanisms, and management. J Alzheimers Dis. 2014; 42(3):739-55. DOI: 10.3233/JAD-140324. View

Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J . Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms. J Alzheimers Dis. 2018; 65(3):793-806. DOI: 10.3233/JAD-170387. View

Lowe Jr W, Meyer T, Karpen C, Lorentzen L . Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology. 1992; 130(5):2683-91. DOI: 10.1210/endo.130.5.1572288. View

Verkhratsky A, Rodrigues J, Pivoriunas A, Zorec R, Semyanov A . Astroglial atrophy in Alzheimer's disease. Pflugers Arch. 2019; 471(10):1247-1261. DOI: 10.1007/s00424-019-02310-2. View

DSouza A, Dave K, Stetler R, Manickam D . Targeting the blood-brain barrier for the delivery of stroke therapies. Adv Drug Deliv Rev. 2021; 171:332-351. DOI: 10.1016/j.addr.2021.01.015. View

Dolleman-van der Weel M, Griffin A, Ito H, Shapiro M, Witter M, Vertes R . The nucleus reuniens of the thalamus sits at the nexus of a hippocampus and medial prefrontal cortex circuit enabling memory and behavior. Learn Mem. 2019; 26(7):191-205. PMC: 6581009. DOI: 10.1101/lm.048389.118. View

Nestler E, Barrot M, DiLeone R, Eisch A, Gold S, Monteggia L . Neurobiology of depression. Neuron. 2002; 34(1):13-25. DOI: 10.1016/s0896-6273(02)00653-0. View

10.

Golan M, Schreiber G, Avissar S . Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway. Int J Neuropsychopharmacol. 2011; 14(10):1289-300. DOI: 10.1017/S1461145710001550. View

11.

Peng S, Wuu J, Mufson E, Fahnestock M . Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem. 2005; 93(6):1412-21. DOI: 10.1111/j.1471-4159.2005.03135.x. View

12.

den Heijer T, van der Lijn F, Koudstaal P, Hofman A, van der Lugt A, Krestin G . A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010; 133(Pt 4):1163-72. DOI: 10.1093/brain/awq048. View

13.

Lee T, Jarome T, Li S, Kim J, Helmstetter F . Chronic stress selectively reduces hippocampal volume in rats: a longitudinal magnetic resonance imaging study. Neuroreport. 2009; 20(17):1554-8. PMC: 2783199. DOI: 10.1097/WNR.0b013e328332bb09. View

14.

Boekhoorn K, Joels M, Lucassen P . Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis. 2006; 24(1):1-14. DOI: 10.1016/j.nbd.2006.04.017. View

15.

Heine V, Maslam S, Zareno J, Joels M, Lucassen P . Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur J Neurosci. 2004; 19(1):131-44. DOI: 10.1046/j.1460-9568.2003.03100.x. View

16.

Chesik D, De Keyser J . Progesterone and dexamethasone differentially regulate the IGF-system in glial cells. Neurosci Lett. 2009; 468(3):178-82. DOI: 10.1016/j.neulet.2009.10.051. View

17.

Chen B, Dowlatshahi D, MacQueen G, Wang J, Young L . Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001; 50(4):260-5. DOI: 10.1016/s0006-3223(01)01083-6. View

18.

Quesseveur G, Gardier A, Guiard B . The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Curr Drug Targets. 2013; 14(11):1277-94. DOI: 10.2174/13894501113149990209. View

19.

Verkhratsky A, Parpura V, Rodriguez-Arellano J, Zorec R . Astroglia in Alzheimer's Disease. Adv Exp Med Biol. 2019; 1175:273-324. PMC: 7266005. DOI: 10.1007/978-981-13-9913-8_11. View

20.

Kirby E, Muroy S, Sun W, Covarrubias D, Leong M, Barchas L . Acute stress enhances adult rat hippocampal neurogenesis and activation of newborn neurons via secreted astrocytic FGF2. Elife. 2013; 2:e00362. PMC: 3628086. DOI: 10.7554/eLife.00362. View